IBDEI1IH ; ; 19-NOV-2015
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;JUN 29, 2015
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,25259,1,3,0)
 ;;=3^CKD,Stage 1
 ;;^UTILITY(U,$J,358.3,25259,1,4,0)
 ;;=4^N18.1
 ;;^UTILITY(U,$J,358.3,25259,2)
 ;;=^5015602
 ;;^UTILITY(U,$J,358.3,25260,0)
 ;;=N18.2^^124^1243^3
 ;;^UTILITY(U,$J,358.3,25260,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,25260,1,3,0)
 ;;=3^CKD,Stage 2
 ;;^UTILITY(U,$J,358.3,25260,1,4,0)
 ;;=4^N18.2
 ;;^UTILITY(U,$J,358.3,25260,2)
 ;;=^5015603
 ;;^UTILITY(U,$J,358.3,25261,0)
 ;;=N18.3^^124^1243^4
 ;;^UTILITY(U,$J,358.3,25261,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,25261,1,3,0)
 ;;=3^CKD,Stage 3
 ;;^UTILITY(U,$J,358.3,25261,1,4,0)
 ;;=4^N18.3
 ;;^UTILITY(U,$J,358.3,25261,2)
 ;;=^5015604
 ;;^UTILITY(U,$J,358.3,25262,0)
 ;;=N18.4^^124^1243^5
 ;;^UTILITY(U,$J,358.3,25262,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,25262,1,3,0)
 ;;=3^CKD,Stage 4
 ;;^UTILITY(U,$J,358.3,25262,1,4,0)
 ;;=4^N18.4
 ;;^UTILITY(U,$J,358.3,25262,2)
 ;;=^5015605
 ;;^UTILITY(U,$J,358.3,25263,0)
 ;;=N18.5^^124^1243^6
 ;;^UTILITY(U,$J,358.3,25263,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,25263,1,3,0)
 ;;=3^CKD,Stage 5
 ;;^UTILITY(U,$J,358.3,25263,1,4,0)
 ;;=4^N18.5
 ;;^UTILITY(U,$J,358.3,25263,2)
 ;;=^5015606
 ;;^UTILITY(U,$J,358.3,25264,0)
 ;;=M02.30^^124^1244^48
 ;;^UTILITY(U,$J,358.3,25264,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,25264,1,3,0)
 ;;=3^Reiter's Disease,Unspec Site
 ;;^UTILITY(U,$J,358.3,25264,1,4,0)
 ;;=4^M02.30
 ;;^UTILITY(U,$J,358.3,25264,2)
 ;;=^5009790
 ;;^UTILITY(U,$J,358.3,25265,0)
 ;;=M10.00^^124^1244^12
 ;;^UTILITY(U,$J,358.3,25265,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,25265,1,3,0)
 ;;=3^Idiopathic Gout,Unspec Site
 ;;^UTILITY(U,$J,358.3,25265,1,4,0)
 ;;=4^M10.00
 ;;^UTILITY(U,$J,358.3,25265,2)
 ;;=^5010284
 ;;^UTILITY(U,$J,358.3,25266,0)
 ;;=M10.9^^124^1244^11
 ;;^UTILITY(U,$J,358.3,25266,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,25266,1,3,0)
 ;;=3^Gout,Unspec
 ;;^UTILITY(U,$J,358.3,25266,1,4,0)
 ;;=4^M10.9
 ;;^UTILITY(U,$J,358.3,25266,2)
 ;;=^5010404
 ;;^UTILITY(U,$J,358.3,25267,0)
 ;;=L40.59^^124^1244^46
 ;;^UTILITY(U,$J,358.3,25267,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,25267,1,3,0)
 ;;=3^Psoriatic Arthropathy NEC
 ;;^UTILITY(U,$J,358.3,25267,1,4,0)
 ;;=4^L40.59
 ;;^UTILITY(U,$J,358.3,25267,2)
 ;;=^5009170
 ;;^UTILITY(U,$J,358.3,25268,0)
 ;;=M32.10^^124^1244^74
 ;;^UTILITY(U,$J,358.3,25268,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,25268,1,3,0)
 ;;=3^Systemic Lupus Erythematosus
 ;;^UTILITY(U,$J,358.3,25268,1,4,0)
 ;;=4^M32.10
 ;;^UTILITY(U,$J,358.3,25268,2)
 ;;=^5011753
 ;;^UTILITY(U,$J,358.3,25269,0)
 ;;=M06.9^^124^1244^49
 ;;^UTILITY(U,$J,358.3,25269,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,25269,1,3,0)
 ;;=3^Rheumatoid Arthritis,Unspec
 ;;^UTILITY(U,$J,358.3,25269,1,4,0)
 ;;=4^M06.9
 ;;^UTILITY(U,$J,358.3,25269,2)
 ;;=^5010145
 ;;^UTILITY(U,$J,358.3,25270,0)
 ;;=M06.4^^124^1244^13
 ;;^UTILITY(U,$J,358.3,25270,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,25270,1,3,0)
 ;;=3^Inflammatory Polyarthropathy
 ;;^UTILITY(U,$J,358.3,25270,1,4,0)
 ;;=4^M06.4
 ;;^UTILITY(U,$J,358.3,25270,2)
 ;;=^5010120
 ;;^UTILITY(U,$J,358.3,25271,0)
 ;;=M19.90^^124^1244^18
 ;;^UTILITY(U,$J,358.3,25271,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,25271,1,3,0)
 ;;=3^Osteoarthritis,Unspec Site
 ;;^UTILITY(U,$J,358.3,25271,1,4,0)
 ;;=4^M19.90
 ;;^UTILITY(U,$J,358.3,25271,2)
 ;;=^5010853
 ;;^UTILITY(U,$J,358.3,25272,0)
 ;;=M19.011^^124^1244^44
 ;;^UTILITY(U,$J,358.3,25272,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,25272,1,3,0)
 ;;=3^Primary Osteoarthritis,Right Shoulder
 ;;^UTILITY(U,$J,358.3,25272,1,4,0)
 ;;=4^M19.011
 ;;^UTILITY(U,$J,358.3,25272,2)
 ;;=^5010808
